279 related articles for article (PubMed ID: 33933067)
1. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
Shi S; Zhang L; Yu Y; Wang C; Li J
BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia.
Ueda M; Inaba M; Tahara H; Imanishi Y; Goto H; Nishizawa Y
Intern Med; 2005 Apr; 44(4):307-10. PubMed ID: 15897641
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature.
Shah R; Licata A; Oyesiku NM; Ioachimescu AG
Pituitary; 2012 Dec; 15 Suppl 1():S17-22. PubMed ID: 21188640
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
Corbetta S; Pizzocaro A; Peracchi M; Beck-Peccoz P; Faglia G; Spada A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):507-12. PubMed ID: 9425388
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia and acromegaly--clarifying the connections. A case report and review of the literature.
Manroa P; Kannan S; Hatipoglu B; Licata A
Endocr Pract; 2014 May; 20(5):e86-90. PubMed ID: 24449661
[TBL] [Abstract][Full Text] [Related]
7. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
Huan C; Cui G; Lu C; Qu X; Han T
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
[TBL] [Abstract][Full Text] [Related]
8. Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
Vilar L; Czepielewsk MA; Naves LA; Rollin GA; Casulari LA; Coelho CE
Endocr Pract; 2007; 13(4):396-402. PubMed ID: 17669717
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
Kovacs CS; Chik CL
J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
[TBL] [Abstract][Full Text] [Related]
11. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly resolution after traumatic brain injury: a case report.
Cob A
J Med Case Rep; 2014 Sep; 8():290. PubMed ID: 25182385
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor].
Carrasco de la Fuente M; González-Albarrán O; Pérez López G; Cano Megías M
Endocrinol Nutr; 2010 Dec; 57(10):507-9. PubMed ID: 20705526
[No Abstract] [Full Text] [Related]
16. Serum phosphate: Does it more closely reflect the true state of acromegaly?
Xie T; Tian P; Wu S; Zhang X; Liu T; Gu Y; Sun C; Hu F
J Clin Neurosci; 2020 Jan; 71():26-31. PubMed ID: 31859176
[TBL] [Abstract][Full Text] [Related]
17. Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.
Ramírez C; Hernández-Ramirez LC; Espinosa-de-los-Monteros AL; Franco JM; Guinto G; Mercado M
BMC Res Notes; 2013 Oct; 6():411. PubMed ID: 24119925
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
19. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
20. [Current diagnosis and treatment of acromegaly].
Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]